Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

BI-Lilly Logo_LockUp-01.jpg
Tiny Check

About Boehringer Ingelheim and Eli Lilly and Company

In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance that centers on compounds representing several of the largest treatment classes. Depending on geographies, the companies either co-promote or separately promote the respective molecules each contributing to the alliance. The alliance leverages the strengths of two of the world’s leading pharmaceutical companies to focus on patient needs. By joining forces, the companies demonstrate their commitment, not only to the care of people, but also to investigating the potential to address areas of unmet medical need.

Handouts

JARDIANCE Brochure

JARDIANCE Now Approved

Click here for full Prescribing Information and Medication Guide for Jardiance® (empagliflozin) tablets.

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
  • Pinterest
Contact Us

Thanks for submitting!